Monday, June 8, 2026

Latest

‘More of an Instinct’: Trump Explains How He’ll Decide Which Companies Get Tariff Exemptions

President Donald Trump revealed Wednesday he may grant exemptions to certain companies hurt by his sweeping tariffs based primarily on his “instinct” rather than established economic analysis.

“You almost can’t take a pencil to paper. It’s really more of an instinct than anything else,” Trump told reporters during a press conference with Treasury Secretary Scott Bessent. “Some companies, through no fault of their own, they happen to be in an industry that is more affected by these things than others.”

The vague process, without established guidelines or oversight, creates a situation where companies may need to appeal directly to the administration for relief. Trump’s statement that “you have to be able to show a little flexibility, and I’m able to do that” suggests a personalized approach to exemptions that could advantage businesses with stronger connections to the White House.

The administration has already carved out exemptions for approximately $644 billion in imports following Trump’s “Liberation Day” tariff announcements, which imposed a 10% universal tariff on imported goods plus higher “reciprocal” tariffs targeting China and European Union countries. 

The Wall Street Journal reports $185 billion of these exemptions benefit goods from Canada and Mexico, though these nations face other trade restrictions.

Trump’s approach to trade policy has introduced significant uncertainty for businesses. His metaphorical explanation about needing to go “under the wall, around the wall or over the wall” when obstacles appear did little to clarify his decision-making process, instead highlighting the unpredictable nature of the exemption system.

Pharmaceutical companies, temporarily exempted while undergoing a Section 232 investigation, may soon face what Trump described as “a major tariff” despite the ongoing review. At a National Republican Congressional Committee dinner Tuesday night, Trump indicated pharmaceutical tariffs would be announced “very soon,” suggesting the investigation’s outcome may already be predetermined.

Related: Kimbal, Elon Musk’s Brother, Calls Out Trump For “Permanent Tax” On US Consumer


Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Gold Trade Is Shifting From Margins to Growth | Geordie Mark – Blue Jay Gold

CopAur Minerals – This PEA Has A Mine Life of What?!

Ontario’s Fast Track to Silver Production Is Starting to Matter | Frank Basa – Nord Precious Metals

Recommended

Antimony Resources Trenching at Bald Hill Averages 19.5% Antimony, Peaks at 44.2%

Amid CBS Shuffle, Is Joe Rogan Replacing Anderson Cooper On 60 Minutes?

Related News

Did Intel Just Give Away 10% Stake To White House For Free?

Intel (NASDAQ: INTC) agreed to a roughly 10% US government stake—structured as a negotiated equity-for-funding...

Monday, August 25, 2025, 12:57:00 PM

Twitter Inc: The Mods Must Be Crazy

With about two weeks left in his term, two days after an angry MAGA mob...

Saturday, January 9, 2021, 05:00:00 PM

Is Saudi Arabia Poised to Profit from a US Imposing Tariffs on Canada Oil?

In a week marked by renewed attention on U.S. energy policy, a debate has emerged...

Thursday, January 23, 2025, 02:04:00 PM

DWAC Briefly Rallies Amid Trump 2024 Possibility

Never mind the failure to solidify a Republican base with some of his endorsed bets...

Tuesday, November 15, 2022, 03:50:00 PM

DEA Stalls While Trump Considers Marijuana Reschedule

President Donald Trump is weighing whether to reclassify marijuana to a less restrictive federal schedule,...

Monday, August 11, 2025, 02:49:00 PM